[1]
J.-F. Zhang, B. Liu, and C.-X. Chen, “Dihydroisoindolo[2,1-a]quinazoline-5,11-dione derivatives as potent and selective inhibitors targeting hepatitis B virus”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 612–620, Jul. 2015.